PRF1 and COVID-19: Those CD8+ T-cells that were present were found to be highly activated in a subset of COVID-19 patients as measured by KI67 and HLA-DR+CD38 expression (161) and appear to retain their cytotoxic capacity as measured by IFNγ, granzyme B, perforin, and CD107a production or expression (137) (Figure 2C).